Keyphrases
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
Xenograft
100%
Trastuzumab
100%
Zirconium-89 (89Zr)
100%
Tumor
25%
Protein Level
16%
Positron Emission Tomography
16%
Tumor Uptake
16%
No Significant Difference
8%
Cholesterol
8%
Tumor Subtype
8%
Cell Surface
8%
Statins
8%
Expression Level
8%
Promising Strategies
8%
Copper-64 (64Cu)
8%
Pharmacological Approaches
8%
Two-level
8%
Tumoral
8%
Biomarker Analysis
8%
Complementary Method
8%
Heterogeneous Tumors
8%
High Heterogeneity
8%
Lovastatin
8%
Radioimmunoconjugate
8%
Pharmacology, Toxicology and Pharmaceutical Science
Trastuzumab
100%
Zirconium 89
100%
Epidermal Growth Factor Receptor 2
100%
Gamma Urogastrone
100%
Copper 64
100%
Neoplasm
58%
Biological Marker
8%
Statin (Protein)
8%
Mevinolin
8%
Neuroscience
Epidermal Growth Factor Receptor 2
100%
Gamma Urogastrone
100%
Trastuzumab
100%
Positron Emission Tomography
16%
Statin
8%
Lovastatin
8%
Immunology and Microbiology
Xenograft
100%
Trastuzumab
100%
Gamma Urogastrone
100%
Positron Emission Tomography
16%
Cell Surface
8%